LMAT Q2 2025 Earnings — LeMaitre Vascular, Inc. Revenue & Financial Results | Market Cap Arena

LMATLeMaitre Vascular, Inc.

$3B

Q2 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$64M+15.0% YoY

Gross Profit

$45M70.0% margin

Operating Income

$16M25.1% margin

Net Income

$14M21.5% margin

EPS (Diluted)

$0.60

QoQ Revenue Growth

+7.3%

Cash Flow

Operating Cash Flow

$20M

Free Cash Flow

$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$578M

Total Liabilities

$215M

Stockholders' Equity

$363M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$64M	$56M	+15.0%
Gross Profit	$45M	$38M	+16.9%
Operating Income	$16M	$14M	+12.3%
Net Income	$14M	$12M	+16.5%

Revenue Segments

Operating Segments

$64M100%

Geographic Segments

UNITED STATES

$37M60%

Other Countries

$16M26%

GERMANY

$4M7%

CANADA

$4M6%